PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer

Lucia Baratto; Hong Song; Heying Duan; Negin Hatami; Hilary P. Bagshaw; Mark Buyyounouski; Steven Hancock; Sumit Shah; Sandy Srinivas; Patrick Swift; Farshad Moradi; Guido Davidzon; Andrei Iagaru

doi:10.2967/jnumed.120.259630

Research ArticleClinical Investigation

PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer

Lucia Baratto, Hong Song, Heying Duan, Negin Hatami, Hilary P. Bagshaw, Mark Buyyounouski, Steven Hancock, Sumit Shah, Sandy Srinivas, Patrick Swift, Farshad Moradi, Guido Davidzon and Andrei Iagaru

Journal of Nuclear Medicine November 2021, 62 (11) 1545-1549; DOI: https://doi.org/10.2967/jnumed.120.259630

Lucia Baratto

1Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hong Song

1Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Heying Duan

1Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Negin Hatami

1Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hilary P. Bagshaw

2Department of Radiation Oncology, Stanford University, Stanford, California; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark Buyyounouski

2Department of Radiation Oncology, Stanford University, Stanford, California; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Steven Hancock

2Department of Radiation Oncology, Stanford University, Stanford, California; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sumit Shah

3Department of Medicine, Division of Oncology, Stanford University, Stanford, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sandy Srinivas

3Department of Medicine, Division of Oncology, Stanford University, Stanford, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Patrick Swift

2Department of Radiation Oncology, Stanford University, Stanford, California; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Farshad Moradi

1Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Guido Davidzon

1Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrei Iagaru

1Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue 11

November 1, 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer

Lucia Baratto, Hong Song, Heying Duan, Negin Hatami, Hilary P. Bagshaw, Mark Buyyounouski, Steven Hancock, Sumit Shah, Sandy Srinivas, Patrick Swift, Farshad Moradi, Guido Davidzon, Andrei Iagaru

Journal of Nuclear Medicine Nov 2021, 62 (11) 1545-1549; DOI: 10.2967/jnumed.120.259630

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer

Lucia Baratto, Hong Song, Heying Duan, Negin Hatami, Hilary P. Bagshaw, Mark Buyyounouski, Steven Hancock, Sumit Shah, Sandy Srinivas, Patrick Swift, Farshad Moradi, Guido Davidzon, Andrei Iagaru

Journal of Nuclear Medicine Nov 2021, 62 (11) 1545-1549; DOI: 10.2967/jnumed.120.259630

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Gastrin-Releasing Peptide Receptor Imaging and Therapy in the Era of Personalized Medicine
Prospective Comparison of 68Ga-NeoB and 68Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate Cancer
Preclinical Comparison of the 64Cu- and 68Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [68Ga]Ga-AMTG PET/CT
A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Evaluation of Prostate Cancer Response to High-Intensity Focused Ultrasound Therapy
Correlation of 68Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
Substitution of L-Tryptophan by {alpha}-Methyl-L-Tryptophan in 177Lu-RM2 Results in 177Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability

Google Scholar

Keywords

68Ga-RM2
68Ga-PSMA11
18F-DCFPyL
PET
prostate cancer

Main menu

User menu

Search

PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords